Related Experiment Video
Updated: May 19, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Myeloma kidney: improving clinical outcomes?
Richard Haynes1, Nelson Leung, Robert Kyle
1Oxford Kidney Unit, Churchill Hospital, Oxford, United Kingdom. richard.haynes@ctsu.ox.ac.uk
Advances in Chronic Kidney Disease
|August 28, 2012
Summary
Multiple myeloma often causes kidney problems, but new treatments like bortezomib improve outcomes. Research is ongoing to further enhance kidney recovery for myeloma patients.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Renal impairment affects 20-40% of multiple myeloma patients, ranging from mild to severe acute kidney injury.
- Kidney impairment in myeloma is linked to poor prognosis due to large tumor burden.
- Despite improved myeloma survival with novel agents, renal complications remain a concern.
Purpose of the Study:
- To review the impact of novel therapies on renal outcomes in multiple myeloma.
- To discuss current and emerging strategies for managing myeloma-related kidney disease.
- To assess the evolving prognosis for patients with myeloma kidney.
Main Methods:
- Review of current literature on multiple myeloma and renal impairment.
- Analysis of the efficacy of novel agents (e.g., bortezomib) in reducing light chain production.
- Evaluation of the role of high cutoff dialysis in managing nephrotoxic light chains.
Main Results:
- Novel agents and autologous stem cell transplantation improve overall survival, including for patients with renal impairment.
- High-dose dexamethasone and bortezomib show potential for rapid light chain reduction and renal recovery.
- Plasma exchange has shown limited benefit, while high cutoff dialysis is under investigation for improved light chain removal.
Conclusions:
- Outcomes for patients with myeloma kidney are improving due to advancements in chemotherapy and supportive care.
- Novel therapies offer a more optimistic outlook for renal prognosis in multiple myeloma.
- Further clinical trials are essential to confirm the benefits of emerging treatments and dialysis techniques.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:22Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...